MENLO PARK, Calif.--(BUSINESS WIRE)--In the media contact information, the email address should read: mbrokaw@spiroxmed.com (instead of mbrokaw@spirox.med.com). The corrected release reads: SPIROX ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Spirox™, Inc., a company committed to transforming treatment of nasal obstruction, today announced the first US cases with the LATERA™ Absorbable Nasal Implant ...
More than 20 million Americans suffer from nasal obstruction, which restricts breathing and impacts quality of life. Whether it’s caused by allergies, a deviated septum or swelling inside your nose, ...
MENLO PARK, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., now a part of Stryker, today announced the publication of positive data from prospective, multicenter OR and Office studies ...
Replacing a complicated surgery with a minimally invasive approach is a tried and true formula in medtech. Menlo Park, California-based startup Spirox is aiming to do that with its device to treat ...
Spirox is touting results from a study of its Latera absorbable nasal implant, a device designed to fight nasal valve collapse and obstruction. Latera is an absorbable polymer implant that supports ...
CHICAGO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Dr. Jordan Pritikin and Dr. Nadia Caballero (Chicago Nasal & Sinus Center) are among the first in the Chicago area to offer the LATERA ® absorbable nasal ...
Positive data supporting the use of Spirox's LATERA for the treatment of nasal valve collapse published in Facial Plastic Surgery "These results are very promising, as they demonstrate the safety and ...
More than 20 million Americans suffer from nasal obstruction, which restricts breathing and impacts quality of life. Whether it's caused by allergies, a deviated septum or swelling inside your nose, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results